Xiaofang Li1, Wenhao Shi1, Yan'e Gao2, Juanzi Shi1, Na Li3, Haiyan Bai4. 1. Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, 710003, People's Republic of China. 2. Department of Gynecology and Obstetrics, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710003, People's Republic of China. 3. Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, 710003, People's Republic of China. linasmiling@126.com. 4. Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, 710003, People's Republic of China. bhy1212@126.com.
Abstract
PURPOSE: To investigate the relationship between different duration of estrogen administration and live birth rate (LBR) after autologous single frozen blastocyst transfer with hormone replacement therapy. METHODS: A total of 2026 frozen blastocyst transfer cycles in the assisted reproductive center of northwest women and children's hospital from January, 2017, to August, 2020, were retrospectively analyzed. All the cycles were allocated into 3 groups according to the duration of estrogen administration: group A, 11-14 days (n = 346); group B, 15-18 days (n = 1191), and group C, ≥ 19 days (n = 489). Baseline data, clinical, and perinatal outcomes of the three groups were compared. A multivariate regression model was constructed to analyze the association between duration of estradiol administration and clinical outcomes. RESULTS: We did not observe a significant association between duration of estrogen supplementation and LBR in group B (adjusted odds ratio [aOR] 1.14; 95% confidence interval [CI], 0.89-1.45) or group C (aOR 1.16; 95% CI, 0.86-1.56) patients with group A as the reference group, through logistic regression analysis. No statistical differences were observed in perinatal outcomes among the three groups. CONCLUSION: The duration of estrogen administration was not associated with the likelihood of live birth in women undergoing frozen-thawed autologous single-blastocyst transfer.
PURPOSE: To investigate the relationship between different duration of estrogen administration and live birth rate (LBR) after autologous single frozen blastocyst transfer with hormone replacement therapy. METHODS: A total of 2026 frozen blastocyst transfer cycles in the assisted reproductive center of northwest women and children's hospital from January, 2017, to August, 2020, were retrospectively analyzed. All the cycles were allocated into 3 groups according to the duration of estrogen administration: group A, 11-14 days (n = 346); group B, 15-18 days (n = 1191), and group C, ≥ 19 days (n = 489). Baseline data, clinical, and perinatal outcomes of the three groups were compared. A multivariate regression model was constructed to analyze the association between duration of estradiol administration and clinical outcomes. RESULTS: We did not observe a significant association between duration of estrogen supplementation and LBR in group B (adjusted odds ratio [aOR] 1.14; 95% confidence interval [CI], 0.89-1.45) or group C (aOR 1.16; 95% CI, 0.86-1.56) patients with group A as the reference group, through logistic regression analysis. No statistical differences were observed in perinatal outcomes among the three groups. CONCLUSION: The duration of estrogen administration was not associated with the likelihood of live birth in women undergoing frozen-thawed autologous single-blastocyst transfer.
Authors: Annemieke Kasius; Janine G Smit; Helen L Torrance; Marinus J C Eijkemans; Ben Willem Mol; Brent C Opmeer; Frank J M Broekmans Journal: Hum Reprod Update Date: 2014-03-23 Impact factor: 15.610
Authors: Lucky Sekhon; Jessica Feuerstein; Stephanie Pan; Jessica Overbey; Joseph A Lee; Christine Briton-Jones; Eric Flisser; Daniel E Stein; Tanmoy Mukherjee; Lawrence Grunfeld; Benjamin Sandler; Alan B Copperman Journal: Fertil Steril Date: 2019-04-24 Impact factor: 7.329
Authors: Maria Cerrillo; Leyre Herrero; Alfredo Guillén; Mercedes Mayoral; Juan Antonio García-Velasco Journal: Rambam Maimonides Med J Date: 2017-04-28